Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey Conn

Showing results (1-10 of 416) with videos related to

Pageof 42
Sort By:
Trends in Pharmacological Sciences|April 11, 2012
An interview with P. Jeffrey ConnP Jeffrey Conn
Future Medicinal Chemistry|September 13, 2013
Interview: interview with P Jeffrey Conn. Interview by Hannah CoakerP Jeffrey Conn
Annals of the New York Academy of Sciences|December 20, 2003
Physiological roles and therapeutic potential of metabotropic glutamate receptorsP Jeffrey Conn
Molecular Pharmacology|March 5, 2022
Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of SchizophreniaShalini Dogra, P Jeffrey Conn
Neuropharmacology|June 27, 2021
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disordersShalini Dogra, P Jeffrey Conn
Neuron|March 4, 2016
Novel PAMs Targeting NMDAR GluN2A SubunitZixiu Xiang, P Jeffrey Conn
Future Neurology|April 1, 2015
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaAyan Ghoshal, P Jeffrey Conn
Current Opinion in Pharmacology|December 3, 2014
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychoticsAdam G Walker, P Jeffrey Conn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Promise of mGluR2/3 activators in psychiatryP Jeffrey Conn, Carrie K Jones
Molecular Pharmacology|March 27, 2015
Molecular Insights into Metabotropic Glutamate Receptor Allosteric ModulationKaren J Gregory, P Jeffrey Conn
Pageof 42

Showing results (1-10 of 416) with videos related to

Sort By:
Pageof 42
Trends in Pharmacological Sciences|April 11, 2012
An interview with P. Jeffrey ConnP Jeffrey Conn
Future Medicinal Chemistry|September 13, 2013
Interview: interview with P Jeffrey Conn. Interview by Hannah CoakerP Jeffrey Conn
Annals of the New York Academy of Sciences|December 20, 2003
Physiological roles and therapeutic potential of metabotropic glutamate receptorsP Jeffrey Conn
Molecular Pharmacology|March 5, 2022
Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of SchizophreniaShalini Dogra, P Jeffrey Conn
Neuropharmacology|June 27, 2021
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disordersShalini Dogra, P Jeffrey Conn
Neuron|March 4, 2016
Novel PAMs Targeting NMDAR GluN2A SubunitZixiu Xiang, P Jeffrey Conn
Future Neurology|April 1, 2015
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophreniaAyan Ghoshal, P Jeffrey Conn
Current Opinion in Pharmacology|December 3, 2014
Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychoticsAdam G Walker, P Jeffrey Conn
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2008
Promise of mGluR2/3 activators in psychiatryP Jeffrey Conn, Carrie K Jones
Molecular Pharmacology|March 27, 2015
Molecular Insights into Metabotropic Glutamate Receptor Allosteric ModulationKaren J Gregory, P Jeffrey Conn
Pageof 42